[Candida albicans meningitis in infancy. Pathogenesis, clinical aspects and chemotherapy].
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001555:Benzene Derivatives / Q000627:therapeutic use; D001593:Benzyl Compounds / Q000627:therapeutic use; D002176:Candida albicans; D002177:Candidiasis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D003596:Cytosine / Q000627:therapeutic use; D004987:Ethers / Q000627:therapeutic use; D005461:Fluorine / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007223:Infant; D008581:Meningitis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology
D000935:Antifungal Agents; D001555:Benzene Derivatives; D001593:Benzyl Compounds; D004987:Ethers; D007093:Imidazoles; D005461:Fluorine; D000666:Amphotericin B; D003596:Cytosine
Candida-albicans-Meningitis im Säuglingsalter. Pathogenese, Klinik und Chemotherapie